According
to the study ‘HYPERTHYROIDISM
GLOBAL CLINICAL TRIALS REVIEW, H1, 2018’, among the most popular
remedies is radioactive iodine (RAI) which is taken orally and gets absorbed by
the thyroid gland. It is meant to destroy the hyper functioning thyroid tissues
which can help reduce symptoms. RAI is generally safe and has been used for
decades and is still undergoing research by scientists who are attempting to
better understand the most commonly used Iodine-131.
Hyperthyroidism
is a condition in which an overactive thyroid gland is producing an excessive
amount of thyroid hormones, such as thyroxine and triiodothyronine that
circulate in the blood. Common symptoms of hyperthyroidism include restlessness,
agitation, anxiety, weight loss despite increased appetite, intolerance to heat
and frequent bowel movements among others. Graves’ disease I s the most common
cause of hyperthyroidism and can be associated with eye disease (Graves’
opthalmopathy). Patients with hyperthyroidism have multiple options for
treatment and management depending on factors like age, physical condition,
underlying causes of the disease, personal preference and severity of the
condition. However, modern study is exploring the possibility of
hyperthyroidism being connected to cancerous tissues. Thyroid cancer starts in
the thyroid gland and its prevalence in patients with hyperthyroidism varies.
This variation stems from factors like extent of histological examination of
removed thyroid tissue, the cause and extent of hyperthyroidism, criteria for
choosing surgery in the treatment of hyperthyroidism and geographical
differences in cancer rates. The overall prevalence of thyroid cancer found during
surgery in patients with hyperthyroidism ranges from a low level to a
significant level. The majority of carcinomas reported in these studies were micro
carcinomas, the clinical significance of which is uncertain. Papillary
carcinoma was the most frequently reported cancer type.
Many
global associations have been established in response to the growing concern.
These institutions annually focus on themes thereby bringing expertise to the
table to augment developments in the field for instance, The Asia-Pacific
Society of Thyroid Surgery will meet in December 2018 to discuss thyroid
surgery. It will discuss newly developed technologies including molecular
diagnoses, intraoperative neuromonitoring, endoscopic and robotic surgery among
others. Researchers have also come together and experimented with Iodine-131 on
mice. Other developments are also taking place in similar radiology therapies
and nuclear medicine. Such future prospects aim to be more target oriented and
minimize after effects of these treatments such as under-activity of the
thyroid gland after consumption of radioactive iodine. The American Thyroid
Association is among the leading institutions in the world that specializes in
thyroid research.
Studies
are also trying to establish connections between the causes of hyperthyroidism
and cancerous tissues that develop in the thyroid gland. The link between
Graves’ hyperthyroidism and cancer remains debatable with the cancer rates
appearing to range widely. Hence, researchers state that clinicians that treat
hyperthyroidism patients should be aware of the outlined malignancy risk
involved. Every suspicious thyroid nodule that is linked to hyperthyroidism
should be carefully evaluated. In addition, nuclear medicine and radiology are
also picking up pace to improve their efficiency.
To know more, click on the link below:
Related Report:
https://www.kenresearch.com/healthcare/pharmaceuticals/hyperthyroidism-global-clinical/35768-91.html
Contact Us:
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
